Robin L. Jones - Search Results

Year	Number of Results
2003	1
2004	2
2005	3
2006	6
2007	8
2008	6
2009	4
2010	11
2011	11
2012	10
2013	19
2014	15
2015	19
2016	27
2017	31
2018	29
2019	26
2020	47
2021	52
2022	39
2023	27
2024	7

1

Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine.

Arfan S, Thway K, Jones RL, Huang PH. Arfan S, et al. Among authors: jones rl. Curr Treat Options Oncol. 2024 Apr 24. doi: 10.1007/s11864-024-01204-5. Online ahead of print. Curr Treat Options Oncol. 2024. PMID: 38656686 Review.

2

Best Overall Response-associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE.

Liu J, Moura DS, Jones RL, Aggarwal A, Philip EJ, Wagner AJ, Wright J, Martín-Broto J, Tap WD. Liu J, et al. Among authors: jones rl. Clin Cancer Res. 2024 Mar 27. doi: 10.1158/1078-0432.CCR-23-3936. Online ahead of print. Clin Cancer Res. 2024. PMID: 38536068

3

Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study.

Lim SY, Ferro-López L, Barquin E, Lindsay D, Thway K, Smith MJ, Benson C, Jones RL, Napolitano A. Lim SY, et al. Among authors: jones rl. Cancers (Basel). 2024 Feb 28;16(5):985. doi: 10.3390/cancers16050985. Cancers (Basel). 2024. PMID: 38473346 Free PMC article.

4

The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments.

Robinson D, Leonard H, Baldi GG, Tap WD, Jones RL, Stacchiotti S, Pantziarka P. Robinson D, et al. Among authors: jones rl. Front Oncol. 2024 Feb 26;14:1367237. doi: 10.3389/fonc.2024.1367237. eCollection 2024. Front Oncol. 2024. PMID: 38469238 Free PMC article.

5

Real-world evidence for ultra rare cancers.

Mavroeidis L, Napolitano A, Huang P, Jones RL. Mavroeidis L, et al. Among authors: jones rl. Rare Tumors. 2024 Feb 15;16:20363613241234207. doi: 10.1177/20363613241234207. eCollection 2024. Rare Tumors. 2024. PMID: 38371426 Free PMC article. No abstract available.

6

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.

Heinrich MC, Jones RL, George S, Gelderblom H, Schöffski P, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Reichmann W, Sprott K, Achour H, Sherman ML, Ruiz-Soto R, Blay JY, Bauer S. Heinrich MC, et al. Among authors: jones rl. Nat Med. 2024 Feb;30(2):498-506. doi: 10.1038/s41591-023-02734-5. Epub 2024 Jan 5. Nat Med. 2024. PMID: 38182785 Free PMC article. Clinical Trial.

7

Reply to Chen, A.; Zhang, X. Comment on "Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. Cancers 2023, 15, 4081".

Golčić M, Jones RL, Huang P, Napolitano A. Golčić M, et al. Among authors: jones rl. Cancers (Basel). 2023 Nov 28;15(23):5619. doi: 10.3390/cancers15235619. Cancers (Basel). 2023. PMID: 38067323 Free PMC article.

8

Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.

Heinrich MC, Zhang X, Jones RL, George S, Serrano C, Deng Y, Bauer S, Cai S, Wu X, Zhou Y, Tao K, Zheng Z, Zhang J, Cui Y, Cao H, Wang M, Hu J, Yang J, Li J, Shen L. Heinrich MC, et al. Among authors: jones rl. Clin Cancer Res. 2024 Feb 16;30(4):719-728. doi: 10.1158/1078-0432.CCR-23-1861. Clin Cancer Res. 2024. PMID: 38032349 Clinical Trial.

9

Recent advances in the systemic treatment of gastrointestinal stromal tumors.

Jones RL, Golčić M. Jones RL, et al. Cancer Biol Med. 2023 Oct 20;20(10):701-5. doi: 10.20892/j.issn.2095-3941.2023.0302. Cancer Biol Med. 2023. PMID: 37874125 Free PMC article. No abstract available.

10

Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas.

Attia S, Villalobos V, Hindi N, Wagner AJ, Chmielowski B, Oakley GJ 3rd, Peterson PM, Ceccarelli M, Jones RL, Dickson MA. Attia S, et al. Among authors: jones rl. Cancers (Basel). 2023 Oct 6;15(19):4871. doi: 10.3390/cancers15194871. Cancers (Basel). 2023. PMID: 37835565 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

358 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Results by year